Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600156 · ClinicalTrials.gov registry record · NA
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02600156: Completed NA study, sponsored by Mayo Clinic.
NCT02600156 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02600156, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the feasibility and safety of MRI-guided focal laser ablation (Laser-Induced Interstitial Thermal Therapy, LITT) to treat low-risk native prostate cancer.
Primary Outcome
To evaluate the procedural success rate of using the MR-guided laser ablation to target, access, thermally monitor, and focally ablate MR-visible prostate cancer lesions.
Interventions
- PROCEDURE Focal laser ablation of the prostate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2025-12-09 |
| Phase | NA |
What the finished NCT02600156 record still lists
NCT02600156 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Focal laser ablation of the prostate is the first listed.
NCT02600156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02600156 about?
NCT02600156 is a clinical study titled "Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors". The primary purpose of this study is to evaluate the feasibility and safety of MRI-guided focal laser ablation (Laser-Induced Interstitial Thermal Therapy, LITT) to treat low-risk native prostate cancer.
What is the current status of trial NCT02600156?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2015-09-01. Estimated completion is 2025-12-09.
What interventions are being tested in trial NCT02600156?
The interventions under investigation include: Focal laser ablation of the prostate (PROCEDURE).
Who is sponsoring clinical trial NCT02600156?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02600156's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI